首页> 外文期刊>JAMA: the Journal of the American Medical Association >Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.
【24h】

Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.

机译:在定期健康检查中筛查轻度甲状腺功能衰竭:一项决策和成本效益分析。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To estimate the cost-effectiveness of periodic screening for mild thyroid failure by measurement of serum thyroid stimulating hormone (TSH) concentration. DESIGN: Cost-utility analysis using a state-transition computer decision model that accounted for case finding, medical consequences of mild thyroid failure, and costs of care during 40 years of simulated follow-up. SETTING: Periodic health examinations in offices of primary care physicians. PATIENTS: Hypothetical cohorts of women and men screened every 5 years during the recommended periodic examination, beginning at age 35 years. INTERVENTIONS: Adding the serum TSH assay to total serum cholesterol screening was compared to cholesterol screening alone. MAIN OUTCOME MEASURES: Discounted quality-adjusted life years (QALYs) and direct medical costs from a societal perspective. RESULTS: The cost-effectiveness of screening 35-year-old patients with a serum TSH assay every 5 years was Dollars 9223 per QALY for women and Dollars 22595 per QALY for men. The cost-effectiveness became more favorable when age at first screening was increased for both sexes and was always more favorable for women than men. Reduced progression to overt hypothyroidism and relief of symptoms increased QALYs, but did not substantially reduce direct medical costs. Finding hypercholesterolemia induced by mild thyroid failure reduced direct medical costs, but did not substantially increase QALYs. The cost of a TSH assay and the importance to patients of symptoms associated with thyroid failure were the most influential factors in sensitivity analyses. CONCLUSIONS: The cost-effectiveness of screening for mild thyroid failure compares favorably with other generally accepted preventive medical practices. Physicians should consider measuring serum TSH concentration in patients aged 35 years and older undergoing routine periodic health examinations. The cost-effectiveness of screening is most favorable in elderly women.
机译:目的:通过测量血清甲状腺刺激激素(TSH)浓度,评估定期筛查轻度甲状腺功能衰竭的成本效益。设计:使用状态转换计算机决策模型进行成本效用分析,该模型考虑了病例发现,轻度甲状腺功能衰竭的医疗后果以及40年模拟随访期间的护理费用。地点:初级保健医生办公室的定期健康检查。患者:在建议的定期检查中,从35岁开始,每5年对假设的男女队列进行一次筛查。干预措施:将血清TSH分析添加到总血清胆固醇筛查中与仅进行胆固醇筛查进行了比较。主要观察指标:从社会角度出发,打折的质量调整生命年(QALYs)和直接医疗费用。结果:每5年用血清TSH检测筛查35岁患者的成本效益是女性每QALY 9223美元,男性每QALY 22595美元。当男女初次筛查的年龄增加时,成本效益变得更加有利,并且女性总是比男性更有利。明显的甲状腺功能减退症的进展减少和症状的缓解增加了QALYs,但并未显着降低直接医疗费用。发现由轻度甲状腺功能衰竭引起的高胆固醇血症降低了直接医疗费用,但并未大幅增加QALY。 TSH分析的成本以及与甲状腺功能衰竭相关的症状对患者的重要性是敏感性分析中最有影响力的因素。结论:筛查轻度甲状腺功能衰竭的成本效益优于其他普遍接受的预防性医疗措施。医师应考虑测量接受常规定期健康检查的35岁及35岁以上患者的血清TSH浓度。筛查的成本效益最适合老年妇女。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号